Clarivate (CLVT) AI Stock Analysis

• Market Cap: $2.25B
• Dividend Yield: N/A
• Average Volume (3M): 3.80M
• Price to Earnings (P/E): ―
• Beta (1Y): 1.00
• Revenue Growth: -2.96%
• EPS Growth: 71.30%
• Country: US
• Employees: 12,000
• Sector: Technology
• Sector Strength: 88
• Industry: Information Technology Services
• EPS (TTM): 0.18
• Shares Outstanding: 661,435,060
• 10 Day Avg. Volume: 3,471,456
• 30 Day Avg. Volume: 3,804,707
• PEG Ratio: 0.16
• Price to Book (P/B): 0.69
• Price to Sales (P/S): 1.38
• P/FCF Ratio: 9.86
• Enterprise Value/Market Cap: 2.99
• Enterprise Value/Revenue: 2.69
• Enterprise Value/Gross Profit: 4.09
• Enterprise Value/Ebitda: 9.31
• 1Y Price Target: $4.80
• Price Target Upside: 41.18% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 5

• Rating: 49 Neutral
• Price Target: $3.50 ▲(2.94% Upside)

Clarivate's overall stock score reflects significant challenges in financial performance and valuation, with ongoing losses and a negative P/E ratio. Technical analysis indicates a bearish trend, further weighing on the score. However, positive developments from the earnings call, such as improvements in contract value and strategic initiatives in AI and product innovation, provide some optimism for future growth.

Positive Factors

AI and Product Innovation

The launch of AI-powered capabilities and new products enhances Clarivate's competitive edge and supports long-term growth by expanding its offerings and improving customer engagement.

Improved Contract Value

The increase in annual contract value indicates stronger customer relationships and potential for sustained revenue growth, reflecting the effectiveness of strategic initiatives.

Debt Reduction

Reducing debt enhances financial stability and flexibility, allowing Clarivate to allocate resources towards growth initiatives and shareholder value creation.

Negative Factors

Revenue Growth Challenges

Negative revenue growth reflects difficulties in expanding market share and generating sales, which could hinder long-term profitability and competitive positioning.

Ongoing Profitability Issues

Sustained negative profit margins indicate operational inefficiencies and challenges in converting revenue into profit, affecting long-term financial health.

Intellectual Property Segment Challenges

Flat revenue in the IP segment suggests difficulties in achieving growth, potentially impacting Clarivate's ability to capitalize on its core competencies in the long term.

Clarivate Business Overview & Revenue Model

Company Description

Clarivate Plc, an information services and analytics company, provides structured information and analytics for discovery, protection, and commercialization of scientific research, innovations, and brands. It offers Web of Science products and services, such as Web of Science, InCites, Journal Citation Reports, EndNote, ScholarOne, Converis, Publons, and Kopernio to organizations that plan, fund, implement, and utilize research; and Life Sciences products, including Cortellis and Newport Integrity for pharmaceutical and biotechnology companies to support research, market intelligence, and competitive monitoring in connection with the development and commercialization of new drugs. The company also provides Derwent products, which include Derwent Innovation, Techstreet, and IP Professional Services that enables its customers to evaluate the novelty of potential new products, confirm freedom to operate with respect to their product design, help them secure patent protection, assess the competitive technology landscape, and ensure that their products comply with required industry standards; CompuMark products, such as trademark screening, searching, and watching products and services for businesses and law firms; and MarkMonitor products, which helps enterprises to establish, manage, optimize, and protect their online presence. It serves government and academic institutions, life science companies, and research and development corporations in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc is headquartered in London, the United Kingdom.

How the Company Makes Money

Clarivate generates revenue through a combination of subscription-based services, software licenses, and transactional services. Its key revenue streams include subscription fees for access to its databases and analytical tools, which are utilized by researchers and institutions. The company also earns revenue from licensing its proprietary datasets and providing consulting services to help clients optimize their research and intellectual property strategies. Significant partnerships with universities, research institutions, and corporations enhance its reach and credibility in the market, contributing to a steady flow of income. Additionally, Clarivate's investment in expanding its product offerings and entering new markets plays a crucial role in driving growth and profitability.

Clarivate Financial Statement Overview

Summary

Clarivate's financial statements reveal challenges in profitability and cash flow growth, despite a stable balance sheet. The income statement highlights ongoing losses, while the balance sheet shows a moderate leverage position. Cash flow management is adequate but could be improved to support growth.

Income Statement

Clarivate's income statement shows a mixed performance. While the company has achieved a modest revenue growth of 3.6% in the TTM, it continues to face challenges with profitability. The net profit margin remains negative at -15.83%, indicating ongoing losses. The gross profit margin is relatively strong at 65.76%, but the negative EBIT margin of -1.29% highlights operational inefficiencies. Overall, the income statement reflects a company struggling to convert revenue into profit.

Balance Sheet

The balance sheet of Clarivate indicates a moderate financial position. The debt-to-equity ratio of 0.91 suggests a balanced approach to leveraging, but the negative return on equity of -7.89% is concerning, as it indicates that the company is not generating positive returns for its shareholders. The equity ratio of 43.67% shows a reasonable level of equity financing. Overall, the balance sheet reflects a stable but not particularly strong financial foundation.

Cash Flow

Clarivate's cash flow statement presents a mixed picture. The operating cash flow to net income ratio of 0.41 indicates that the company is generating cash from operations, but the free cash flow growth rate is negative at -3.12%, suggesting challenges in maintaining cash flow growth. The free cash flow to net income ratio of 0.55 shows that a portion of the losses is being offset by free cash flow. Overall, the cash flow statement suggests moderate cash management with room for improvement.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	2.50B	2.56B	2.63B	2.66B	1.88B	1.88B
Gross Profit	1.64B	1.69B	1.72B	1.71B	1.25B	1.25B
EBITDA	721.90M	456.60M	-10.50M	-3.01B	532.15M	52.38M
Net Income	-396.00M	-636.70M	-911.20M	-3.96B	-270.50M	-270.45M
Balance Sheet
Total Assets	11.23B	11.49B	12.71B	13.94B	13.94B	20.18B
Cash, Cash Equivalents and Short-Term Investments	318.70M	295.20M	370.70M	348.80M	348.80M	430.88M
Total Debt	4.48B	4.59B	4.81B	5.10B	5.10B	5.61B
Total Liabilities	6.32B	6.35B	6.71B	7.13B	7.13B	8.26B
Stockholders Equity	4.90B	5.14B	5.99B	6.81B	6.81B	11.93B
Cash Flow
Free Cash Flow	335.20M	357.50M	501.70M	306.40M	205.30M	205.22M
Operating Cash Flow	609.90M	646.60M	744.20M	509.30M	323.80M	323.77M
Investing Cash Flow	-171.10M	-236.70M	-237.40M	57.30M	-4.04B	-4.04B
Financing Cash Flow	-504.80M	-470.10M	-496.50M	-759.20M	4.03B	4.03B

Clarivate Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 3.40
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CLVT, the sentiment is Negative. The current price of 3.4 is below the 20-day moving average (MA) of 3.61, below the 50-day MA of 3.93, and below the 200-day MA of 4.20, indicating a bearish trend. The MACD of -0.12 indicates Positive momentum. The RSI at 37.45 is Neutral, neither overbought nor oversold. The STOCH value of 18.03 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for CLVT.

Clarivate Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
CTSH	―	$35.18B	16.89	14.50%	1.72%	7.44%	-4.57%
EPAM	―	$9.11B	23.32	11.36%	―	9.73%	-0.29%
IT	―	$18.81B	15.28	116.13%	―	5.89%	54.53%
EXLS	―	$6.21B	26.48	25.96%	―	14.43%	29.86%
G	―	$6.65B	12.66	21.86%	1.74%	7.37%	-14.64%
Sector *	―	$37.18B	12.37	-10.20%	1.83%	8.50%	-7.62%
CLVT	―	$2.25B	-5.95	-7.60%	―	-2.96%	71.30%

Clarivate Corporate Events

Clarivate Plc Reports Improved Q3 2025 Results

Clarivate Plc is a leading global provider of transformative intelligence, offering enriched data, insights, analytics, workflow solutions, and expert services in the areas of Academia & Government, Intellectual Property, and Life Sciences & Healthcare.

Clarivate Plc’s Earnings Call: Optimism Amid Challenges

Clarivate Plc’s recent earnings call revealed a cautious optimism, as the company reported improvements in contract value and renewal rates, alongside robust financial management through debt reduction and share repurchases. Despite these positive strides, challenges persist in revenue growth and profitability, particularly within the Intellectual Property segment. The company’s strategic focus on AI and product innovation highlights potential avenues for future growth.

Clarivate Raises 2025 Revenue Outlook Amid Q3 Results

On October 29, 2025, Clarivate reported its third-quarter results, highlighting improved financial and operational performance. The company raised its 2025 revenue outlook and reported a net loss reduction compared to the previous year. Despite a slight decrease in organic revenues, Clarivate saw growth in organic ACV and an improvement in the mix of organic recurring revenue. The company repurchased 11.7 million ordinary shares and repaid $100 million of debt in the third quarter, demonstrating a commitment to shareholder value.

The most recent analyst rating on (CLVT) stock is a Hold with a $3.50 price target. To see the full list of analyst forecasts on Clarivate stock, see the CLVT Stock Forecast page.

Clarivate Increases Revolving Credit by $75 Million

On August 5, 2025, Clarivate Plc’s subsidiaries amended their existing Credit Agreement, originally dated October 31, 2019, to increase the total revolving credit commitments by $75 million, bringing the total to $775 million. This amendment, which maintains the same terms as the existing agreement, is expected to enhance Clarivate’s financial flexibility and support its operational and strategic initiatives.

The most recent analyst rating on (CLVT) stock is a Hold with a $4.50 price target. To see the full list of analyst forecasts on Clarivate stock, see the CLVT Stock Forecast page.

Clarivate Plc Reports Q2 2025 Earnings and Outlook

Clarivate Plc is a leading global provider of transformative intelligence, offering enriched data, insights, analytics, workflow solutions, and expert services in the areas of Academia & Government, Intellectual Property, and Life Sciences & Healthcare.

Clarivate Plc’s Mixed Earnings Call: Growth Amid Challenges

The recent earnings call for Clarivate Plc presented a mixed sentiment, reflecting both positive strides and ongoing challenges. The company showcased notable organic growth in key metrics and strong cash flow generation, which were overshadowed by a reported net loss and the impact of ongoing disposals. Despite these hurdles, Clarivate demonstrated progress in strategic initiatives and maintained high renewal rates, particularly in the Academic & Government (A&G) segment.